Search

BAYER AKTIENGESELLSCHAFT

The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish

    • 18/07/2019
    • 13:09
    • BAYER AKTIENGESELLSCHAFT
    • Strategic plans, profit forecasts and presentations
    • Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with colorectal cancer
    • Register number: 280294
    • Price sensitive information of BAYER AKTIENGESELLSCHAFT